Organicell

02/14/2023

Did you know that February 14th is also ? Today is a day dedicated to spreading awareness and education about organ, eye, and tissue donation. Organicell would like to highlight the importance of donating perinatal tissue to help advance the research and development of biologic medicine. Share the love!

Carolyn Delucia

11/17/2022

Organicell Starts Enrolling Trial

MIAMI, FL / ACCESSWIRE / November 17, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB: OCEL), a clinical-stage biopharmaceutical company

11/15/2022

Organicell announces Mayo Clinic in Phoenix, Arizona will be the clinical trial site for their Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Zofin for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).

DAVIE, FL / ACCESSWIRE / November 15, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company focused

10/11/2022

Organicell Announces Additions to Board of Directors

Expanded Board of Director Broadens Company’s Access to Valued Business Expertise and Relationships

Expanded Board of Director Broadens Company's Access to Valued Business Expertise and Relationships

09/20/2022

Organicell Announces Expansion of Management Team, recruiting a new Chief Operating Officer, Chief Information Officer, and Director of Finance.

Read the full press release here:

MIAMI, FL / ACCESSWIRE / September 20, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company focused on

09/16/2022

Organicell Regenerative Medicine, Inc. Announces Expansion into Health and Beauty Market

Read the full press release here:

MIAMI, FL / ACCESSWIRE / September 16, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company focused on

09/14/2022

BeautyHealth’s Hydrafacial Announces Partnership with Organicell to Develop Breakthrough Exosome Booster to Address Aging and Inflammation through Regenerative Technology.

Read the full press release here:

Co-Created with Organicell, the first-to-market booster will address aging and inflammation through regenerative technology

09/09/2022

Organicell Regenerative Medicine, Inc. Secures Additional $11 Million in Financing in Preparation for Clinical Trial Enrollment

Read the full Press Release here:

MIAMI, FL / ACCESSWIRE / September 9, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company focused

08/31/2022

Organicell Regenerative Medicine, Inc. announced the broad-based engagement of top international law firm McDermott Will & Emery, widely considered to have the best health care practice in the nation.

Read the full press release:

MIAMI, FL / ACCESSWIRE / August 30, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally

07/26/2022

Organicell Regenerative Medicine, Inc. announced today that the board of directors has appointed Matt Sinnreich as Chief Operating Officer and acting CEO.

MIAMI, FL / ACCESSWIRE / July 26, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally